GenMark aims to raise another $30m in second public offering
This article was originally published in Clinica
Executive Summary
Molecular diagnostics specialist GenMark Diagnostics has announced plans to raise around $30m in a public share offering, just over a year after it launched its IPO on the Nasdaq.